SEC Form 4 · accession 0001144204-15-071683
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Edward Fernandez
Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 16, 2015 | P | 6,821 | $29.32 | A | 6,821 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Thomas Edward Fernandez acquired 6,821 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Thomas Edward Fernandez in the transaction was $199,991.72.